v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Series C Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Subscription Receivable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at the beginning at Dec. 31, 2024 $ 15,507,000              
Balance at the beginning (in shares) at Dec. 31, 2024 973,000              
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) (69,000)              
Series C convertible preferred stock conversion $ (866,000)              
Balance at the end at Mar. 31, 2025 $ 14,641,000              
Balance at the end (in shares) at Mar. 31, 2025 904,000              
Balance at the beginning at Dec. 31, 2024   $ 1,328,000 $ 1,344,720,000   $ (79,000) $ (1,443,499,000) $ 3,043,000 $ (94,487,000)
Balance at the beginning (in shares) at Dec. 31, 2024   1,328,622,000            
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 2,000 864,000         866,000
Series C convertible preferred stock conversion (in shares)   1,720,000            
Issuance of common stock for cash, net   $ 23,000 5,100,000         5,123,000
Issuance of common stock for cash, net (in shares)   22,747,000            
Warrants exercised for cash     17,000         17,000
Warrants exercised for cash (in shares)   76,000            
Issuance of common stock for conversion of debt and accrued interest   $ 38,000 9,566,000         9,604,000
Issuance of common stock for conversion of debt and accrued interest (in shares)   38,013,000            
Stock-based compensation     385,000         385,000
Stock-based compensation (in shares)   75,000            
Warrant modifications     265,000         265,000
Deemed dividend related to warrant modifications     (265,000)         (265,000)
Net loss           (19,343,000)   (19,343,000)
Cumulative translation adjustment             (1,644,000) (1,644,000)
Balance at the end at Mar. 31, 2025   $ 1,391,000 1,360,652,000   (79,000) (1,462,842,000) 1,399,000 (99,479,000)
Balance at the end (in shares) at Mar. 31, 2025   1,391,253,000            
Balance at the beginning at Dec. 31, 2025 $ 12,710,000              
Balance at the beginning (in shares) at Dec. 31, 2025 784,347              
Increase (Decrease) in Temporary Equity Deficit                
Series C convertible preferred stock conversion (in shares) (17,000)              
Series C convertible preferred stock conversion $ (226,000)              
Balance at the end at Mar. 31, 2026 $ 12,484,000              
Balance at the end (in shares) at Mar. 31, 2026 766,747              
Balance at the beginning at Dec. 31, 2025   $ 1,567,000 1,442,830,000 $ (12,000) (79,000) (1,503,661,000) (925,000) $ (60,280,000)
Balance at the beginning (in shares) at Dec. 31, 2025   1,567,433,000            
Balance at the beginning (in shares) at Dec. 31, 2025       (12,000,000)       12,000,000
Increase (Decrease) in Stockholders' Deficit                
Series C convertible preferred stock conversion   $ 1,000 225,000         $ 226,000
Series C convertible preferred stock conversion (in shares)   440,000            
Issuance of common stock for cash, net   $ 12,000 2,888,000         2,900,000
Issuance of common stock for cash, net (in shares)   12,388,000            
Warrants exercised for cash     6,000         6,000
Warrants exercised for cash (in shares)   25,000            
Cashless warrant exercise (in shares)   140,000            
Issuance of common stock for conversion of debt and accrued interest   $ 39,000 8,850,000         8,889,000
Issuance of common stock for conversion of debt and accrued interest (in shares)   38,431,000            
Stock-based compensation     288,000         288,000
Warrant modifications     331,000         331,000
Deemed dividend related to warrant modifications     (331,000)         (331,000)
Net loss           (3,069,000)   (3,069,000)
Cumulative translation adjustment             496,000 496,000
Balance at the end at Mar. 31, 2026   $ 1,619,000 $ 1,455,087,000 $ (12,000) $ (79,000) $ (1,506,730,000) $ (429,000) $ (50,544,000)
Balance at the end (in shares) at Mar. 31, 2026   1,618,857,000            
Balance at the end (in shares) at Mar. 31, 2026       (12,000,000)       12,000,000